Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK
1 other identifier
observational
46
1 country
1
Brief Summary
The objective of this study is to gather clinical data on SI-LOK® for the treatment of sacroiliac joint dysfunction. The purpose of this prospective study is to evaluate clinical and radiographic outcomes, intra-operative parameters, patient satisfaction and work status following a procedure using SI-LOK® for treatment of sacroiliac joint dysfunction with a minimum of three screws.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2013
CompletedFirst Submitted
Initial submission to the registry
May 21, 2013
CompletedFirst Posted
Study publicly available on registry
May 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 11, 2019
CompletedSeptember 11, 2020
September 1, 2020
5.2 years
May 21, 2013
September 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Radiographic Evaluation
Fusion Assessment Radiolucency
2 years
Secondary Outcomes (1)
Hospitalization Data
Intra-Operative
Other Outcomes (1)
Composite of Patient Self-Assessments
2 years
Study Arms (1)
SI-Joint Dysfunction
Device- SI-LOK
Interventions
Eligibility Criteria
Patients will be screened according to inclusion/exclusion criteria and will be selected for the treatment using the SI-LOK® system
You may qualify if:
- A maximum age of 70 years
- Diagnosis of SIJ dysfunction
- Ability to provide Informed Consent for study participation and to return for all follow-up visits
You may not qualify if:
- Previous documentation of osteopenia or osteomalacia
- History of metabolic bone disease (e.g. diabetes requiring daily insulin)
- Diagnosis of a condition or requires postoperative medication(s), which may interfere with bony/soft tissue healing
- Presence of a disease entity or condition which totally precludes possibility of bony fusion (e.g. metastatic cancer, HIV, long term use of steroids, etc.)
- History of substance abuse (drugs or alcohol)
- Condition that would preclude completing patient self assessment questionnaires
- Mentally incompetent or prisoner
- Currently a participant in another study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern Medical Center
Saint Albans, Vermont, 05478, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Barnum, MD
Northwestern Medical Center, St Albans, VT 05478
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2013
First Posted
May 24, 2013
Study Start
May 2, 2013
Primary Completion
July 5, 2018
Study Completion
April 11, 2019
Last Updated
September 11, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share